BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33641552)

  • 1. Emerging therapeutic targets for sepsis.
    Tindal EW; Armstead BE; Monaghan SF; Heffernan DS; Ayala A
    Expert Opin Ther Targets; 2021 Mar; 25(3):175-189. PubMed ID: 33641552
    [No Abstract]   [Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic coordination of acute systemic inflammation: potential therapeutic targets.
    Vachharajani V; Liu T; McCall CE
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1141-50. PubMed ID: 25088223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis in the critically ill patient: current and emerging management strategies.
    Heming N; Azabou E; Cazaumayou X; Moine P; Annane D
    Expert Rev Anti Infect Ther; 2021 May; 19(5):635-647. PubMed ID: 33140679
    [No Abstract]   [Full Text] [Related]  

  • 5. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to the development of anti-sepsis drugs.
    Lehmann C; Sharawi N; Al-Banna N; Corbett N; Kuethe JW; Caldwell CC
    Expert Opin Drug Discov; 2014 May; 9(5):523-31. PubMed ID: 24697209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and systems biology approaches to signal transduction in sepsis.
    Nguyen A; Yaffe MB
    Crit Care Med; 2003 Jan; 31(1 Suppl):S1-6. PubMed ID: 12544970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways and intervention therapies in sepsis.
    Zhang YY; Ning BT
    Signal Transduct Target Ther; 2021 Nov; 6(1):407. PubMed ID: 34824200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Toll-Like Receptors in Sepsis: From Bench to Clinical Trials.
    Chen F; Zou L; Williams B; Chao W
    Antioxid Redox Signal; 2021 Nov; 35(15):1324-1339. PubMed ID: 33588628
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
    McBride MA; Patil TK; Bohannon JK; Hernandez A; Sherwood ER; Patil NK
    Front Immunol; 2020; 11():624272. PubMed ID: 33613563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics.
    Rodrigues PRS; Picco N; Morgan BP; Ghazal P
    Expert Opin Drug Discov; 2021 May; 16(5):537-551. PubMed ID: 33206027
    [No Abstract]   [Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring immunomodulation in patients with sepsis.
    Kyriazopoulou E; Giamarellos-Bourboulis EJ
    Expert Rev Mol Diagn; 2021 Jan; 21(1):17-29. PubMed ID: 33183116
    [No Abstract]   [Full Text] [Related]  

  • 16. Insights into sepsis therapeutic design based on the apoptotic death pathway.
    Hattori Y; Takano K; Teramae H; Yamamoto S; Yokoo H; Matsuda N
    J Pharmacol Sci; 2010; 114(4):354-65. PubMed ID: 21081836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses.
    Matsuda A; Jacob A; Wu R; Aziz M; Yang WL; Matsutani T; Suzuki H; Furukawa K; Uchida E; Wang P
    J Nippon Med Sch; 2012; 79(1):4-18. PubMed ID: 22398786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis, immunosuppression and the role of epigenetic mechanisms.
    Córneo EDS; Michels M; Dal-Pizzol F
    Expert Rev Clin Immunol; 2021 Feb; 17(2):169-176. PubMed ID: 33596148
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetics of Sepsis.
    Binnie A; Tsang JLY; Hu P; Carrasqueiro G; Castelo-Branco P; Dos Santos CC
    Crit Care Med; 2020 May; 48(5):745-756. PubMed ID: 32167492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunopathogenesis of sepsis.
    Cohen J
    Nature; 2002 Dec 19-26; 420(6917):885-91. PubMed ID: 12490963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.